Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study

BACKGROUND: Non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations often develop brain metastases. Treatment with EGFR-tyrosine kinase inhibitors (TKIs) has shown the effectiveness; however, knowledge of the clinical factors associated with outcomes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yung-Hsuan, Chen, Yen-Fu, Chen, Chung-Yu, Shih, Jin-Yuan, Yu, Chong-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815404/
https://www.ncbi.nlm.nih.gov/pubmed/31655564
http://dx.doi.org/10.1186/s12885-019-6140-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815404/
https://www.ncbi.nlm.nih.gov/pubmed/31655564
http://dx.doi.org/10.1186/s12885-019-6140-0

Ejemplares similares